Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

753
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
753
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.7K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

98
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
98
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

10.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
10.3K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

56
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
56
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Continuous-Time State-Space Models for Marked Event Sequences.

Advances in neural information processing systems·2026
Same author

A Survey on Unifying Large Language Models and Knowledge Graphs for Biomedicine and Healthcare.

KDD : proceedings. International Conference on Knowledge Discovery & Data Mining·2026
Same author

BIPEFT: Budget-Guided Iterative Search for Parameter Efficient Fine-Tuning of Large Pretrained Language Models.

Findings of ACL. EMNLP. Conference on Empirical Methods in Natural Language Processing·2025
Same author

TrialBench: Multi-Modal AI-Ready Datasets for Clinical Trial Prediction.

Scientific data·2025
Same author

A perspective for adapting generalist AI to specialized medical AI applications and their challenges.

NPJ digital medicine·2025
Same author

MediSim: Multi-granular simulation for enriching longitudinal, multi-modal electronic health records.

Patterns (New York, N.Y.)·2025
Same journal

3DICE: Interpretable 3D Cross-Modal Learning for Drug-Target Interaction Prediction and Large-Scale Drug Discovery.

Bioinformatics (Oxford, England)·2026
Same journal

KASSPer: Kinase Active Site Structure Prediction using Protein and Ligand Language Models and Its Application to Virtual Screening.

Bioinformatics (Oxford, England)·2026
Same journal

IDR searcher: a search engine solution for public image resources.

Bioinformatics (Oxford, England)·2026
Same journal

KCFtools: Rapid alignment-free method for introgression screening and GWAS using k-mer profiles.

Bioinformatics (Oxford, England)·2026
Same journal

Meta2DB: Curated shotgun metagenomic feature sets and metadata for health state prediction.

Bioinformatics (Oxford, England)·2026
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Nov 11, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

872

SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization.

Yue Yu1, Kexin Huang2, Chao Zhang1

  • 1College of Computing, Georgia Institute of Technology, Atlanta, GA 30332, USA.

Bioinformatics (Oxford, England)
|March 26, 2021
PubMed
Summary
This summary is machine-generated.

SumGNN, a novel knowledge summarization graph neural network, effectively integrates large biomedical knowledge graphs for improved drug-drug interaction (DDI) prediction. This method enhances multi-typed DDI detection and offers interpretable reasoning paths.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K

Related Experiment Videos

Last Updated: Nov 11, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

872
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K

Area of Science:

  • Biomedical Informatics
  • Machine Learning
  • Pharmacology

Background:

  • Accurate drug-drug interaction (DDI) detection is crucial for patient safety.
  • Large biomedical knowledge graphs (KGs) offer rich information but are challenging to utilize effectively due to size and noise.
  • Existing methods often ignore KGs or struggle to integrate them with other data for DDI prediction, particularly for multi-typed interactions.

Purpose of the Study:

  • To develop a novel method, SumGNN (knowledge summarization graph neural network), for enhanced multi-typed DDI prediction.
  • To effectively leverage large and noisy biomedical KGs by extracting relevant subgraphs and summarizing reasoning paths.
  • To improve the accuracy and interpretability of DDI predictions, especially in data-scarce scenarios.

Main Methods:

  • SumGNN employs a subgraph extraction module to identify relevant information within large KGs.
  • A self-attention mechanism is used for subgraph summarization, generating interpretable reasoning paths.
  • A multi-channel module integrates KG knowledge with other data for improved DDI prediction.

Main Results:

  • SumGNN significantly outperforms existing methods in multi-typed DDI prediction, achieving up to a 5.54% performance gain.
  • The performance improvement is particularly notable for low-frequency DDI types.
  • The model provides interpretable predictions through generated reasoning paths.

Conclusions:

  • SumGNN offers an effective approach to utilizing large biomedical KGs for accurate and interpretable DDI prediction.
  • The method addresses limitations of previous approaches by successfully integrating noisy KG data.
  • SumGNN advances the field of DDI prediction, especially for complex, multi-typed interactions.